Visit booth #1/2 at BOS Basel 2026 to discover how our integrated
CDMO and CRO capabilities can help streamline your drug development journey.
June 30–July 1, 2026 | Basel, Switzerland | Booth #1/2
Biotech Outsourcing Strategies (BOS) Basel 2026 will bring together R&D outsourcing leaders from across the biopharma industry to share insights, strengthen partnerships, and build new business relationships.
Focused on development-stage CMC for small molecules, biologics, and novel therapeutic entities, the event features high-quality networking opportunities and a dynamic exhibition of CRO and CDMO capabilities.
Date: June 30–July 1, 2026
Location: Congress Center Basel
Booth Number: #1/2
Event Website: BOS Basel 2026
At BOS Basel 2026, connect with Thermo Fisher Scientific’s global team of drug development experts to explore how we simplify development-stage outsourcing.
Through Accelerator™ Drug Development, we integrate CDMO and CRO capabilities across CMC, clinical research, manufacturing, and supply—seamlessly supporting programs across therapeutic areas and modalities.
Our connected approach reduces complexity, improves continuity, and helps keep your program on track from preclinical development through commercialization.
We look forward to seeing you in Basel. Pre-book a meeting with our team to start the conversation.
Stay connected to new discoveries, innovations, and expert scientific opinions.
Follow us on social media for the latest up-to-date event happenings.
Please complete the form below to request a meeting. Be sure to include your preferred topic and any specific details, and a member of our team will follow up with you shortly.